No Data
No Data
Compass Therapeutics Names Barry Shin CFO
Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Trevena Appoints Katrine Sutton as New CFO
Trevena Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Trevena Analyst Ratings
H.C. Wainwright Downgrades Trevena(TRVN.US) to Hold Rating, Cuts Target Price to $5
No Data
Tonyco : $bluebird bio (BLUE.US)$
$X4 Pharmaceuticals (XFOR.US)$
$Edible Garden (EDBL.US)$
HailTheApocalypse Tonyco : I would scratch out Blueturd.